Due to the Covid-19 virus outbreak, Evonik’s contract manufacturer had to shut-down its production facilities for TreAmino. Both production and shipping of the amino acid ThreAmino (L-threonine) are affected.
Dr. Emmanuel Auer, Head of Animal Nutrition Business Line at Evonik, explained: “Regrettably, we are facing a supply shortage for ThreAmino. We have therefore decided to send a Force Majeure notification to our customers with immediate effect, in accordance with our contracts.”
Auer is insuring custumors that Evonik is trying to mitigate this situation and re-establish supply to its customers as fast as possible. “We keep our customers informed regularly as the situation develops.”
Evonik is one of the world leaders in specialty chemicals. The company is active in more than 100 countries around the world.